Our future work will be to evaluate the association of POSTN exon 21 with the invasion and metastatic potential of tongue cancer and to test the efficacy of a POSTN exon 21-specific neutralizing antibody as an inhibitor of lymph node metastasis. The gene discussed is POSTN; the disease is tongue cancer.